Soleno Therapeutics provides a regulatory update on DCCR for Prader-Willi Syndrome. FDA Review Division states no need for advisory committee meeting for the New Drug Application.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Soleno Therapeutics, Inc. (SLNO) Stock Price, News, Quote & History - Yahoo Finance
